CRISPR/Cas9 technology targeting the 5 of exon 2 and the 3 of exon 3 generated an in-frame deletion of amino acids 10 to 21 (128 bp deletion). This deletion should block formation of the first SYCE1-4930447C04Rik binding interface. (J:314193)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count